<DOC>
	<DOCNO>NCT00948649</DOCNO>
	<brief_summary>The goal propose study validate experimental paradigm assess medication effect smoke relapse follow brief ( 3-day ) monitor period smoking abstinence program cigarette lapse .</brief_summary>
	<brief_title>Effects Chantix Relapse Prevention Smoking Cessation</brief_title>
	<detailed_description>The propose human experiment test validity novel paradigm may provide method distinguish compound likely efficacy , test costly large-scale clinical trial . Specifically , within-subject ( cross-over ) behavioral pharmacology investigation 60 smoker , test effect varenicline versus placebo smoke behavior natural environment follow 3-day period monitor abstinence program cigarette lapse . A positive signal varenicline effect study would provide support sensitivity paradigm . In addition , follow completion assessment , participant follow 13-week open-label varenicline smoke cessation trial determine whether response varenicline laboratory study predict clinical response open-label trial .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Eligible participant 68 ( 34 male 34 female ) smoker age 1865 , smoke ≥ 10 cigarette per day , provide baseline CO reading ≥ 10 ppm plan live area next 6months . Smoking Behavior 1 . Use chew tobacco snuff 2 . Current enrollment plan enroll another smoking cessation program next 5 month 3 . Plan use nicotine substitute smoke cessation treatment next 5 month 4 . Provide baseline CO reading &lt; 10 ppm Alcohol/Drug Exclusion Criteria 1 . History substance abuse and/or currently receive treatment substance abuse ( e.g. , alcohol , opioids , cocaine , marijuana , stimulant ) 2 . Current alcohol consumption exceed &gt; 25 standard drinks/week Medication Exclusion Criteria 1 . Current use recent discontinuation ( within last 14days ) follow medication : 1 . Any form smoking cessation medication ( zyban , wellbutrin , wellbutrin SR , Chantix , NRT ) 2 . Any form antipsychotic medication include : antipsychotic , atypical antipsychotic , moodstabilizers , antidepressant ( tricyclic , SSRI 's , MAOI 's ) , antipanic agent , antiobsessive agent , antianxiety agent , stimulant ( e.g. , Provigil , Ritalin ) . 3 . Medication chronic pain 4 . Anticoagulants 5 . Any heart medication 6 . Daily medication asthma Medical Exclusion Criteria 1 . Women pregnant , planning pregnancy , lactate . 2 . History current diagnosis psychosis , major depression bipolar disorder , schizophrenia , Axis 1 disorder identify SCID . 3 . Serious unstable disease within past 6 month ( e.g. , cancer [ except melanoma ] , heart disease , HIV ) . 4 . History epilepsy seizure disorder . 5 . History current diagnosis ( last 6months ) abnormal rhythm and/or tachycardia ( &gt; 100 beats/minute ) ; history current diagnosis COPD , cardiovascular disease ( stroke , angina , coronary heart disease ) , heart attack last 6 month , uncontrolled hypertension ( SBP &gt; 150 DBP &gt; 90 ) 6 . History Kidney and/or liver failure ( include transplant ) . 7 . Wears device aid hearing ( hear aid , cochlear implant , etc. ) . 8 . Hearing threshold &lt; 40 dB SPL 1000 Hz . 9 . Color blindness . General Exclusion 1 . Any medical condition concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . 2 . Inability provide inform consent complete study task determine Principal Investigator and/or Study Physician . 3 . Any physical visual impairment may prevent individual use computer keyboard complete study task .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Varenicline , Working memory</keyword>
</DOC>